REFINE ICD: Efficacy of ICD therapy in higher risk post-MI patients with better-preserved LV function

Back

ESC Professional Premium Access

REFINE ICD: Efficacy of ICD therapy in higher risk post-MI patients with better-preserved LV function

Session: HOT LINE 3

Topic: Device Treatment

Speaker: Professor D. Exner (Calgary, CA)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Derek Exner

Libin Cardiovascular Institute Of Alberta, Calgary (Canada)

2 presentations

0 follower

7 more presentations in this session

REBOOT-CNIC: betablockers after infarction with LVEF greater than 40%

Speaker: Professor B. Ibanez (Madrid, ES)

THE BETAMI-DANBLOCK TRIAL: RANDOMIZED DISCONTINUATION OF BETA-BLOCKERS AFTER MYOCARDIAL INFARCTION

Speaker: Professor D. Atar (Oslo, NO)

REBOOT/BETAMI/DANBLOCK/CAPITAL-RCT: Beta-Blockers after MI with Mildly Reduced EF (an IPD meta-analysis)

Speaker: Doctor F. Rossello (Palma de Mallorca, ES)

Discussant review - REBOOT-CNIC, BETAMI-DANBLOCK, CAPITAL-RCT

Speaker: Professor J. Cleland (Glasgow, GB)

Access

Slides

Video

Panel discussion - REBOOT-CNIC, BETAMI-DANBLOCK, CAPITAL-RCT

Access

Video

Access the full session

HOT LINE 3

Speakers: Professor D. Exner, Professor B. Ibanez, Professor D. Atar, Doctor F. Rossello, Professor J. Cleland

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources